Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil

June 13, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SEOUL, South Korea, June 13, 2011 /- Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH announced positive results from an initial safety and efficacy portal hypertension study in man using udenafil, its new long-active phosphodiesterase inhibitor. The data was presented by the principal...

HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer

June 13, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

MUMBAI, India, June 13, 2011 /- Pharma Major Lupin Limited announced today that its U.S. subsidiary, Lupin Pharmaceutical Inc. was presented with the 2011 DIANA Award by the Healthcare Distribution Management Association (HDMA) for the Best Overall Generic Product Manufacturer among those...

AACR Mourns the Loss of Laura Ziskin, Co-founder of SU2C

June 13, 2011 7:34 am | by AACR | News | Comments

Tweet   PHILADELPHIA - It is with immense sorrow and deep regret that we share the news of the passing of Laura Ziskin, co-founder of Stand Up To Cancer (SU2C). She was a staunch advocate of the value of cancer research in saving lives, and was a beloved friend and member of our AACR...

Advertisement

PerkinElmer buys X-ray tech firm Dexela

June 13, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Waltham-based PerkinElmer Inc., a scientific instruments and services company, has acquired London-based Dexela Limited, a provider of X-ray detection technologies and services.

Stand Up To Cancer Co-Founder Laura Ziskin Dies at 61

June 13, 2011 6:32 am | by AACR | News | Comments

Los Angeles, CA – Acclaimed film producer and cancer activist Laura Ziskin died today at her home in Santa Monica at the age of 61. Ziskin, who lived with breast cancer for seven years, is survived by her husband, screenwriter Alvin Sargent, with whom she frequently collaborated;...

Thoratec Announces Resignation of Chief Financial Officer

June 10, 2011 12:33 pm | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., June 10, 2011 /- Thoratec Corporation (NASDAQ: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that David V. Smith, Executive Vice President and Chief Financial Officer, has...

BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti

June 9, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J. and OLATHE, Kan., June 9, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, and Heart to Heart International, a humanitarian medical aid nonprofit organization, announced a joint volunteer initiative to strengthen...

ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi

June 9, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. and OXFORD, Miss., June 9, 2011 /- ChromaDex Corp. (OTCBB: CDXC) and the University of Mississippi today announced the university has granted the natural products company the exclusive worldwide patent rights to a potential new therapeutic use for pterostilbene...

Advertisement

European Bioinformatics Institute Drives Genomics Research With GÉANT

June 9, 2011 4:32 am | by RealWire | News | Comments

High-speed GÉANT and JANET research networks enable global collaboration on 1000 Genomes ProjectCambridge, UK, June 9 2011 - The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), which hosts the world's largest public collection of molecular...

Wuzhou Changlian Introduces New Thermometer Series

June 8, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 8, 2011 /PRNewswire-Asia/ -- To thank customers for their continuous support of our health care products including infrared thermometers , heart beat watches, blood pressure monitors and so on, Shenzhen Wuzhou Changlian International Trading Co. has decided to offer...

FDA Approves Updates to Lilly's Humalog® (insulin lispro injection rDNA origin) Label

June 8, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 8, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental new drug application (sNDA) with the following updates to the Humalog label: continuous insulin infusion pump therapy in...

iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan

June 8, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 8, 2011 /- Cellular Dynamics International, Inc. (CDI) today announced an agreement with iPS Academia Japan, Inc ., who will distribute CDI's iCell® Cardiomyocytes , the first commercially available product based on induced pluripotent stem cells (iPSCs), in...

Reportlinker Adds Asia-Pacific Markets for Patient Monitoring Devices 2011

June 8, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 8, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Asia-Pacific Markets for Patient Monitoring Devices 2011...

Advertisement

VEGF Trap-Eye Submitted for EU Marketing Authorization for Treatment of Wet Age-Related Macular Degeneration

June 6, 2011 11:33 pm | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y. and BERLIN, June 7, 2011 /- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of...

Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy

June 4, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 4, 2011 /- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) today announced results from a study that showed treatment with metreleptin, an investigational treatment that is an analog of the human hormone leptin, improved diabetes and lipid control in patients with partial...

Shenzhen Wuzhou Changlian International Trading Co. Announces Arrival of New Infrared Thermometer Series

June 3, 2011 2:33 pm | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 3, 2011 /PRNewswire-Asia/ -- After 3 months of customer opinion surveys at home and abroad, and with great efforts between Shenzhen Wuzhou Changlian International Trading Co. and their partner's technology support, the company has just introduced a brand new series...

Orexigen® Therapeutics Provides a Regulatory Update on Contrave® NDA

June 3, 2011 3:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 3, 2011 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave® (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of...

FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer

June 2, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., June 2, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using...

Isis Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference

June 2, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., June 2, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at Jefferies' 2011 Global Healthcare Conference on Thursday, June 09, 2011 at 11:30 a.m. ET at the Grand...

PLC Ramps Up for U.S. Clinical Trial of RenalGuard®

June 2, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Mass., June 2, 2011 /- PLC Systems Inc. (OTCBB: PLCSF), a company focused on innovative medical device technologies, today announced that it is preparing to commence the pivotal trial in the U.S. for the company's innovative product, RenalGuard®, to seek approval for sales...

SCAA Puts the 'AED' in CPR/AED Week to Make Communities Safer, Better Equipped to Respond to Cardiac Arrest

June 1, 2011 12:32 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 1, 2011 /PRNewswire-USNewswire/ -- For 30 years, the national survival rate of sudden cardiac arrest (SCA) has remained a low six percent. Recognizing the need for expanded awareness of the public health crisis of SCA, the Sudden Cardiac Arrest Association (SCAA) is...

Legs 4 Life, LLC Acquires Venosan North America

June 1, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

ASHEBORO, N.C., June 1, 2011 /- Legs 4 Life, LLC, the parent company of Ames Walker International , proudly announced today that it has acquired Venosan North America, Venosan's American brand and distributorship of Venosan's Swiss made stockings.  The acquisition enables Legs 4 Life...

Alexion lands FDA priority review for blood clotting drug target

June 1, 2011 10:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Alexion Pharmaceuticals Inc. has won priority review from the U.S. Food and Drug Administration for its supplemental Biologics License Application for the company's drug candidate Soliris to treat atypical Hemolytic Uremic Syndrome.

Argos Therapeutics' Arcelisâ„¢ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlat...

June 1, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., June 1, 2011 /- Argos Therapeutics announced today that its Arcelis™ immunotherapy for the treatment of renal cell carcinoma (RCC), AGS-003, in combination with sunitinib demonstrated a strong immunologic response that correlated to improved clinical outcomes. The...

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

June 1, 2011 5:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 1, 2011 /-Reportlinker.com announces that a new market research report is available in its catalogue: Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading